Grant: CIHR Fellowship
University of Toronto
$135,000.00
Role of NLRP6 in intestinal barrier protection
EF 2015-16
Résumé
Inflammatory bowel diseases (IBD) are chronic inflammatory disorders that affect the entire digestive tract; main forms are Crohn's Disease (CD) and ulcerative colitis (UC). IBD has a tremendous impact on quality of life and Canada has one of the highest rates of CD in the world, with an incidence on the rise. There is an unmet medical need to better understand CD pathogenesis since current treatment strategies calm inflammation but do not cure CD. Indeed, an elaborate balance between immune responses and tolerance to intestinal microbiota is required to maintain intestinal homeostasis. Intestinal epithelial cells represent an important physical barrier separating the intestinal lumen with its associated microbiota. Microbiota in the gut constitutes a heterogeneous microbial ecosystem and dysregulation of the homeostasis between intestinal immune systems and microbiota has been associated with the development of IBD in genetically susceptible populations. This physical barrier has several functions and plays a unique role in innate immunity. Receptors, like NOD-like receptors (NLRs), are key players in this surveillance. It is becoming clear that one of these receptors, NLRP6, plays roles in maintaining intestinal homeostasis by promoting mucosal self-renewal and proliferation. NLRP6 is relatively highly expressed in the intestine in mice and more studies are needed to further understand its function. The present proposal will focus on identifying a role of NLRP6 in the small intestine using ex vivo cultures of murine small intestine enteroids combined with in vivo models of ileitis. These studies will identify the significance of NLRP6 in the development of ileitis and will delineate the potential mechanisms involved. Results from these studies will set the stage for the development of improved therapies or the potential to uncover novel drug targets that are the cause of inflammation in the intestine and improve the quality of life of Canadian living with IBD.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
338891
Name
Lemire Paul
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Association of Gastroenterology (Oakville, Ontario)
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Role of NLRP6 in intestinal barrier protection
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Goblet Cells; Ileitis In Vivo Model; Inflammaroty Bowel Disease; Inflammasome; Intestinal Epithelial Cells; Mucine Production; Nlrp6; Nod-Like Receptors; Organoid Culture; Paneth Cells
Abstract
Inflammatory bowel diseases (IBD) are chronic inflammatory disorders that affect the entire digestive tract; main forms are Crohn's Disease (CD) and ulcerative colitis (UC). IBD has a tremendous impact on quality of life and Canada has one of the highest rates of CD in the world, with an incidence on the rise. There is an unmet medical need to better understand CD pathogenesis since current treatment strategies calm inflammation but do not cure CD. Indeed, an elaborate balance between immune responses and tolerance to intestinal microbiota is required to maintain intestinal homeostasis. Intestinal epithelial cells represent an important physical barrier separating the intestinal lumen with its associated microbiota. Microbiota in the gut constitutes a heterogeneous microbial ecosystem and dysregulation of the homeostasis between intestinal immune systems and microbiota has been associated with the development of IBD in genetically susceptible populations. This physical barrier has several functions and plays a unique role in innate immunity. Receptors, like NOD-like receptors (NLRs), are key players in this surveillance. It is becoming clear that one of these receptors, NLRP6, plays roles in maintaining intestinal homeostasis by promoting mucosal self-renewal and proliferation. NLRP6 is relatively highly expressed in the intestine in mice and more studies are needed to further understand its function. The present proposal will focus on identifying a role of NLRP6 in the small intestine using ex vivo cultures of murine small intestine enteroids combined with in vivo models of ileitis. These studies will identify the significance of NLRP6 in the development of ileitis and will delineate the potential mechanisms involved. Results from these studies will set the stage for the development of improved therapies or the potential to uncover novel drug targets that are the cause of inflammation in the intestine and improve the quality of life of Canadian living with IBD.
Competitiondate
201511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Lemire, Paul
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~